DMAC Projected Dividend Yield
DiaMedica Therapeutics Inc ( NASDAQ : DMAC )DiaMedica Therapeutics is a biopharmaceutical company engaged in developing novel therapeutic products to improve the lives of people with Type 1 diabetes, Type 2 diabetes and other significant diseases with unmet medical needs. 20 YEAR PERFORMANCE RESULTS |
DMAC Dividend History Detail DMAC Dividend News DMAC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |